Active, Not Recruiting
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
NCT02091245
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
- Locations
-
- UCSF San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Boston Children's Hospital Boston, Massachusetts, United States